← Leaderboards
David Rosenthal
University Of Pennsylvania
$1,493,810
Attributed
$1,493,810
Total exposure
5
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$1,493,810 · 5
By mechanism
M01$1,493,810 · 5
Top collaborators
No co-investigators on record.
Most similar at University Of Pennsylvania
Same institution · by research overlap
- Amit Maity$4,832,230
- Stephen G Emerson$28,932,839
- Eric J Bernhard$2,381,828
- Constantinos Koumenis$17,144,115
- Stephen M Hahn$5,432,347
Others in their field
Top investigators on “Human Therapy Evaluation”
- Lawrence Corey · Fred Hutchinson Cancer Center$368,153,539
- David Heimbrook · Leidos Biomedical Research, Inc.$241,598,366
- Gerald T Nepom · Benaroya Research Inst At Virginia Mason$212,820,795
- Barbara Driver · Westat, Inc.$206,347,735
- Carol Nesel · Westat$188,148,170
- Constance Ann Benson · University Of California, San Diego$179,950,251
Research focus
Human Therapy EvaluationNeoplasm /Cancer ChemotherapyHuman SubjectClinical ResearchNeoplasm /Cancer Radiation TherapyCombination Cancer TherapyDrug Screening /EvaluationDosageAntineoplasticsClinical Trial Phase IHead /Neck NeoplasmHydrazinesClinical TrialsPaclitaxelPodophyllinPharmacokineticsLung NeoplasmsDrug Administration RoutesDrug Administration Rate /DurationSquamous Cell CarcinomaDrug Adverse EffectNonsmall Cell Lung CancerRadiosensitizerOral Administration
Grant awards (27)
UPCC10397: SPI 77 W/ ADVANCED MALIGNANCIES OF HEAD &NECK$124,146
M01 · FY2002 · RR
UPCC 6597: SPI 77 IN COMBINATION W/ RADIOTHERAPY ADVANCED LUNG CANCER$124,146
M01 · FY2002 · RR
RADIATION THERAPY WITH CONCOMITANT CONTINUOUS INFUSION TAXOL$124,146
M01 · FY2002 · RR
CONTINUOUS INFUSION TAXOL IN COMBINATION WITH THORACIC RADIATION THERAPY$124,146
M01 · FY2002 · RR
RADIATION THERAPY WITH CONCOMITANT CONTINUOUS INFUSION TAXOL$124,146
M01 · FY2001 · RR
CONTINUOUS INFUSION TAXOL IN COMBINATION WITH THORACIC RADIATION THERAPY$124,146
M01 · FY2001 · RR
UPCC10397: SPI 77 W/ ADVANCED MALIGNANCIES OF HEAD &NECK$124,146
M01 · FY2001 · RR
UPCC 6597: SPI 77 IN COMBINATION W/ RADIOTHERAPY ADVANCED LUNG CANCER$124,146
M01 · FY2001 · RR
RADIATION THERAPY WITH CONCOMITANT CONTINUOUS INFUSION TAXOL$0
M01 · FY2001 · RR
UPCC10397: SPI 77 W/ ADVANCED MALIGNANCIES OF HEAD &NECK$0
M01 · FY2001 · RR
UPCC 6597: SPI 77 IN COMBINATION W/ RADIOTHERAPY ADVANCED LUNG CANCER$0
M01 · FY2001 · RR
CONTINUOUS INFUSION TAXOL IN COMBINATION WITH THORACIC RADIATION THERAPY$0
M01 · FY2001 · RR
ORALLY ADMINISTERED TIRAPAZAMINE IN CANCER SUBJECTS RECEIVING RADIOTHERAPY$187,536
M01 · FY2000 · RR
ORALLY ADMINISTERED TIRAPAZAMINE IN CANCER SUBJECTS RECEIVING RADIOTHERAPY$187,536
M01 · FY2000 · RR
ORALLY ADMINISTERED TIRAPAZAMINE IN CANCER SUBJECTS RECEIVING RADIOTHERAPY$25,114
M01 · FY2000 · RR
CONTINUOUS INFUSION TAXOL IN COMBINATION WITH THORACIC RADIATION THERAPY$25,114
M01 · FY2000 · RR
RADIATION THERAPY WITH CONCOMITANT CONTINUOUS INFUSION TAXOL$25,114
M01 · FY2000 · RR
UPCC 6597: SPI 77 IN COMBINATION W/ RADIOTHERAPY ADVANCED LUNG CANCER$25,114
M01 · FY2000 · RR
UPCC10397: SPI 77 W/ ADVANCED MALIGNANCIES OF HEAD &NECK$25,114
M01 · FY2000 · RR
UPCC10397: SPI 77 W/ ADVANCED MALIGNANCIES OF HEAD &NECK$0
M01 · FY2000 · RR
UPCC10397: SPI 77 W/ ADVANCED MALIGNANCIES OF HEAD &NECK$0
M01 · FY2000 · RR
UPCC 6597: SPI 77 IN COMBINATION W/ RADIOTHERAPY ADVANCED LUNG CANCER$0
M01 · FY2000 · RR
UPCC 6597: SPI 77 IN COMBINATION W/ RADIOTHERAPY ADVANCED LUNG CANCER$0
M01 · FY2000 · RR
RADIATION THERAPY WITH CONCOMITANT CONTINUOUS INFUSION TAXOL$0
M01 · FY2000 · RR
RADIATION THERAPY WITH CONCOMITANT CONTINUOUS INFUSION TAXOL$0
M01 · FY2000 · RR
CONTINUOUS INFUSION TAXOL IN COMBINATION WITH THORACIC RADIATION THERAPY$0
M01 · FY2000 · RR
CONTINUOUS INFUSION TAXOL IN COMBINATION WITH THORACIC RADIATION THERAPY$0
M01 · FY2000 · RR